FCGR1A and Sepsis: That said, the value of biomarker panels that include sTREM-1, PCT and CD64 on neutrophils has recently demonstrated the ability to predict sepsis in the setting of unselected critical illness, confirming the need to pursue such discriminatory panels in VAP, as in other disease states [42], [43].